Literature DB >> 3966453

The association of Streptococcus bovis fecal carriage and colon neoplasia: possible relationship with polyps and their premalignant potential.

C A Burns, R McCaughey, C B Lauter.   

Abstract

We designed a study to evaluate the fecal carrier rate of Streptococcus bovis in patients with endoscopically proven colonic polyps. Benign polyps (n = 63), i.e., hyperplastic, inflammatory, and juvenile, had a similar fecal carrier rate as the normal control colons. Colons with polyps that are at increased risk for malignant degeneration (n = 62), i.e., tubulovillous and villous adenomas, and colons with carcinoma (n = 18), had a statistically significant increase (p less than 0.05) in the fecal carrier rate for S. bovis over the benign colon group. Overall, the incidence of S. bovis carriage in all colons with polyps was intermediary between normal colons and colons with carcinoma although the numbers did not achieve statistical significance.

Entities:  

Mesh:

Year:  1985        PMID: 3966453

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  25 in total

1.  Rapid identification of Streptococcus bovis by using combination constitutive enzyme substrate hydrolyses.

Authors:  K J Panosian; S C Edberg
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

2.  Effect of Lactobacillus casei on Streptococcus bovis in faecal flora.

Authors:  Atsuko Kawano; Hideki Ishikawa; Ikuko Akedo; Tomiyo Nakamura; Kazumasa Matsumoto; Hiroo Takayama; Akemi Imaoka; Yoshinori Umesaki; Ryuichiro Tanaka; Toru Otani; Toshiyuki Sakai
Journal:  BMJ Case Rep       Date:  2010-01-13

3.  High-level gentamicin resistance mediated by a Tn4001-like transposon in seven nonclonal hospital isolates of Streptococcus pasteurianus.

Authors:  Viola C Y Chow; Peter M Hawkey; Edward W C Chan; Miu L Chin; T K Au; Danny K C Fung; Raphael C Y Chan
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

4.  Novel real-time PCR assays using TaqMan minor groove binder probes for identification of fecal carriage of Streptococcus bovis/Streptococcus equinus complex from rectal swab specimens.

Authors:  Paulo Guilherme Markus Lopes; Vlademir Vicente Cantarelli; Grasiela Agnes; Ane Micheli Costabeber; Pedro Alves d'Azevedo
Journal:  J Clin Microbiol       Date:  2014-01-03       Impact factor: 5.948

Review 5.  The gut microbiome and colorectal cancer: a review of bacterial pathogenesis.

Authors:  Jessica D Dahmus; Drew L Kotler; David M Kastenberg; C Andrew Kistler
Journal:  J Gastrointest Oncol       Date:  2018-08

6.  Streptococcus gallolyticus: a single bacteria, two different conditions.

Authors:  Cristiano Silva Cruz; Catarina Machado; André Almeida; Rita Barata Moura
Journal:  BMJ Case Rep       Date:  2015-07-01

Review 7.  Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus.

Authors:  Andrea N Burnett-Hartman; Polly A Newcomb; John D Potter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

8.  Catabolite regulation in a diauxic strain and a nondiauxic strain of Streptococcus bovis.

Authors:  D B Kearns; J B Russell
Journal:  Curr Microbiol       Date:  1996-10       Impact factor: 2.188

9.  A collagen-binding adhesin, Acb, and ten other putative MSCRAMM and pilus family proteins of Streptococcus gallolyticus subsp. gallolyticus (Streptococcus bovis Group, biotype I).

Authors:  Jouko Sillanpää; Sreedhar R Nallapareddy; Xiang Qin; Kavindra V Singh; Donna M Muzny; Christie L Kovar; Lynne V Nazareth; Richard A Gibbs; Mary J Ferraro; James M Steckelberg; George M Weinstock; Barbara E Murray
Journal:  J Bacteriol       Date:  2009-08-28       Impact factor: 3.490

10.  Streptococcus bovis/Streptococcus equinus complex fecal carriage, colorectal carcinoma, and infective endocarditis: a new appraisal of a complex connection.

Authors:  C Chirouze; I Patry; X Duval; V Baty; P Tattevin; T Aparicio; M Pagenault; F Carbonnel; G Couetdic; B Hoen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-06       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.